United States President Donald Trump has unveiled a second deal with a major pharmaceutical company to offer lower-cost prescription drugs direct to American consumers.
This time, the agreement concerned AstraZeneca, a multinational based in the United Kingdom.
Recommended Stories
list of 3 itemsend of list
Trump hosted the company’s chief executive, Pascal Soriot, in the Oval Office on Friday to publicly cement the deal, which he described as “another historic achievement in our quest to…
Continue Reading
News Source: www.aljazeera.com

Leave a Reply